Sort
82,697 grants matching “vaccine development”
Towards a Vaccine to Prevent Toxoplasmosis
$827,305Rima L McLeod · University Of Chicago · U01 · FY2011 · AI
NHP Core for Development of an Integrase Defective Lentiviral Vector HIV Vaccine
$827,260Sampa Santra · Duke University · P01 · FY2015 · AI
Immunologic and Metabolic Profiles of T cells that control diverse HCV infections
$827,166Andrea L Cox · Johns Hopkins University · U19 · FY2024 · AI
Preclinical development of human CMV vaccines
$827,143Michael A McVoy · Virginia Commonwealth University · R01 · FY2012 · AI
Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers
$827,143Stephen Philip Schoenberger · La Jolla Institute For Immunology · U01 · FY2020 · DE
Sample Collection and General Screening Protocols
$827,127Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Immune Dysfunction in HIV+ Opioid Users
$827,056Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2022 · DA
Harnessing native glycosylation to improve immunogenicity of HIV-1 Env immunogens
$827,022Chitra Upadhyay · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AI
JHU-MCAIDS HPTN TRIAL SITE-CHINA
$826,937Johns Hopkins University · U01 · FY2004 · AI
Optimizing Antibody Vaccines Against HIV
$826,933William Schief · Massachusetts General Hospital · P01 · FY2013 · AI
Discovery and development of broad spectrum anti-flaviviral drugs
$826,847Timothy A Haystead · Duke University · R01 · FY2014 · AI
Developmental Core- Pilot Projects, Full Projects, Biostat Core and Outreach Prog
$826,822Raymond Nelson Dubois · University Of Tx Md Anderson Can Ctr · U54 · FY2009 · CA
Molecular Genetics Of Scrapie Pathogenesis
$826,800Suzette Alise Priola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Host control in Coccidioidomycosis
$826,754John N Galgiani · University Of Arizona · P01 · FY2008 · AI
Targeting PD-1 Pathway for Functional Cure of AIDS
$826,489Rama Rao Amara · Emory University · R37 · FY2022 · AI
ACTIVE IMMUNOTHERAPY FOR COGNITIVE DECLINE IN ADULTS WITH DOWN SYNDROME
$826,451Michael S Rafii · University Of California, San Diego · R01 · FY2014 · AG
Project 1. Optimization and in vivo evaluation of HIV-1 Env trimer sortase A-conjugated nanoparticles
$826,400Kevin O Saunders · Duke University · U19 · FY2024 · AI
Development of mRNA-platform vaccines
$826,282Fredrick Heath Damron · West Virginia University · R01 · FY2021 · AI
Defining the Immunogenicity and Efficacy of a Durable BCG Vaccine Strategy Optimized for Preventing TB in Pediatric HIV Infection
$826,203Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI
Chromatin infrastructure of the Igh locus and its influence on VH gene usage
$826,195Amy L. Kenter · University Of Illinois At Chicago · R01 · FY2020 · AI
HTS for copper-activated inhibitors against MRSA
$826,146Frank Wolschendorf · University Of Alabama At Birmingham · R01 · FY2016 · AI
Infection-blocking antibody targets for malaria
$826,064Stefan H.i. Kappe · Seattle Children'S Hospital · R01 · FY2020 · AI
Control of Tsetse Fly Transmitted Diseases in Kenya
$825,920Serap Aksoy · Yale University · U01 · FY2019 · AI
Glycopeptide Antigen-bearing Nanoparticles for Passive and Active Antitumor Therapy for Pancreatic Cancer
$825,904Joseph John Barchi · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Epitope-Based Design and Modified RNA Platform for Bivalent Marburgvirus Vaccine
$825,853Alexander Bukreyev · University Of Texas Med Br Galveston · R01 · FY2019 · AI